News

The accuracy of detecting bowel cancer is increased to almost 100 percent by carrying out a common test twice rather than once, a new study shows.

Nanomedicine researchers have devised a new approach to solving a decades-old clinical problem: getting treatment drugs to act selectively on cancer cells and not on healthy cells.

Researchers have found that estrogen can directly cause tumor-driving genomic rearrangements.

Cancer cells can adapt to use uridine as a fuel source when access to glucose is limited, reports a new study from the University of Michigan.

Researchers have identified a mechanism in mice for how obesity affects some oral cancers’ ability to escape from the immune system.

Researchers report on the development of a novel ctDNA-based liquid biopsy approach, Aneuploidy in Circulating Tumor DNA (ACT-Discover), that identifies subclonal copy number alterations in pancreatic cancer evolution.

Those at higher risk had been treated with a specific category of chemotherapy.

A team of researchers has identified that increased nerve density in the oral tumor microenvironment is correlated with poorer clinical outcomes.

Researchers report pre-clinical evidence for an actionable target for the treatment of a type of ESR1 variant-driven, endocrine therapy-resistant breast cancer.

Researchers have discovered a key epigenetic alteration that predicts the clinical course of liver cancer.